| Literature DB >> 20681450 |
Hui Zhao1, Jundong Gu, Hongrui Xu, Bingjun Yang, Youkui Han, Li Li, Shuzhong Liu, Hong Yao.
Abstract
BACKGROUND ANDEntities:
Mesh:
Substances:
Year: 2010 PMID: 20681450 PMCID: PMC6015159 DOI: 10.3779/j.issn.1009-3419.2010.06.010
Source DB: PubMed Journal: Zhongguo Fei Ai Za Zhi ISSN: 1009-3419
纳入研究的基本特征
General characteristics of included trials
| First author | Cases | Controls | Study type | OR | 95%CI | Adjusted OR | Adjusted 95%CI | Years of data Collection | Year of publicaion | Region |
| HU[ | 104 | 163 | Case-control | 2.86 | 1.72-4.76 | — | — | 1990-1993 | 1996 | Guangdong |
| ZHENG[ | 94 | 259 | Case-control | 1.04 | 0.61-1.78 | 1.04 | 0.59-1.85 | 1990-1993 | 1997 | Peking |
| Zhong[ | 504 | 601 | Case-control | 1.15 | 0.85-1.57 | 1.1 | 0.8-1.5 | 1992-1994 | 1999 | Shanghai |
| Gao[ | 246 | 375 | Case-control | 1.19 | 0.82-1.73 | 1.30 | 0.87-1.94 | 1984-1986 | 1987 | Shanghai |
| Ko[ | 105 | 105 | Case-control | 0.86 | 0.46-1.60 | 0.8 | 0.4-1.6 | 1992-1993 | 1997 | Taiwan |
| Wu-Williams[ | 417 | 602 | Case-control | 0.78 | 0.56-1.10 | 0.70 | 0.60-0.90 | 1985-1987 | 1990 | Shenyang |
| Wang[ | 228 | 521 | Case-control | 1.39 | 0.88-2.20 | 1.19 | 0.7-2.0 | 1994-1998 | 2000 | Gansu |
| McGhee[ | 324 | 763 | Case-control | 1.62 | 1.24-2.13 | 1.39 | 1.03-1.88 | 1983-1986 | 2005 | Hong Kong |
| Liu[ | 54 | 202 | Case-control | 0.74 | 0.32-1.69 | 0.77 | 0.30-1.96 | 1985-1986 | 1991 | Xuanwei |
| Lam[ | 199 | 335 | Case-control | 1.65 | 1.16-2.35 | — | — | 1983-1986 | 1987 | Hong Kong |
| Lei[ | 75 | 128 | Case-control | 1.19 | 0.66-2.16 | — | — | — | 1996 | Guangzhou |
| SUN[ | 230 | 230 | Case-control | 4.18 | 2.14-8.16 | 2.86 | 1.69-4.84 | 1985-1991 | 1995 | Haerbin |
| Lee[ | 268 | 445 | Case-control | 1.88 | 1.36-2.60 | — | — | 1992-1998 | 2000 | Taiwan |
| LIU[ | 498 | 595 | Case-control | 1.93 | 1.31-2.83 | 1.65 | 1.10-2.47 | 1992-1993 | 2001 | Shanghai |
| SONG[ | 115 | 124 | Case-control | 2.31 | 1.36-3.90 | — | — | — | 1999 | Haerbin |
| LIN[ | 122 | 122 | Case-control | 1.20 | 0.60-2.39 | — | — | 1985-1990 | 1994 | Haerbin |
| Combined | 3 583 | 5 570 | 1.13 | 1.05-1.21 |
纳入研究16篇文献的质量评价(STROBE声明)
STROBE Statement-checklist criteria included in 16 reports of passive smoking and lung cancer risk
| Items | Recommendations | Number of study[ |
| Title and abstract | 1.1 Indicate the study’s design with a commonly used term in the title or the abstract | 4 (25%) |
| 1.2 Provide in the abstract an informative and balanced summary of what was done | 12 (75%) | |
| Introduction | ||
| Background/rationale | 2 Explain the scientific background and rationale for the investigation being reported | 13 (81.3%) |
| Objectives | 3 State specific objectives, including any prespecified hypotheses | 14 (87.5%) |
| Methods | ||
| Stydy desin | 4 Present key elemens of study design early in the paper | 12 (75%) |
| Setting | 5 Describe the setting, locations, and relevant dates, including periods of recruitment, | 16 (100.0%) |
| Participants | 6.1 Give the eligibility criteria, and the sources and methods of ascertainment, and | 11 (68.6%) |
| 6.2 For matched studies, give matching criteria and the number of controls per case | 9 (56.3%) | |
| Variables | 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect | 8 (50.0%) |
| Datasources/ | 8 For each variable of interest, give sources of data and details of methods of | 10 (62.5%) |
| Bias | 9 Describe any efforts to address potential sources of bias | 2 (12.5%) |
| Study size | 10 Explain how the study size was arrived at | 0 (0) |
| Quantitative variables | 11 Explain how quantitative variables were handled in the analyses. If applicable, | 9 (56.3%) |
| 12.1 Describe all statistical methods, including those used to control for confounding | 14 (87.5%) | |
| 12.2 Describe any methods used to examine subgroups and interactions | 11 (68.8%) | |
| Statistical methods | 12.3 Explain how missing data were addressed | 4 (25%) |
| 12.4 If applicable, explain how matching of cases and controls was addressed | 6 (37.5%) | |
| 12.5 Describe any sensitivity analyses | 4 (25%) | |
| Results | ||
| 13.1 Report numbers of individuals at each stage of study-eg numbers potentially | 13 (81.3%) | |
| Participants | 13.2 Give reasons for non-participation at each stage | 8 (50%) |
| 13.3 Consider use of a flow diagram | 0 (0) | |
| Descriptive data | 14.1 Give characteristics of study participants (eg, demographic, clinical, social) and | 11 (68.8%) |
| 14.2 Indicate number of participants with missing data for each variable of interest | 5 (31.3%) | |
| Outcome data | 15 Report numbers in each exposure category, or summary measures of exposure | 13 (81.3%) |
| 16.1 Give unadjusted estimates and, if applicable, confounder-adjusted estimates | 12 (75%) | |
| 16.2 Report category boundaries when continuous variables were categorized | 11 (68.8%) | |
| 16.3 If relevant, consider translating estimates of relative risk into absolute risk for a | 3 (18.8%) | |
| Other analyses | 17 Report other analyses done-eg analyses of subgroups and interactions, and | 5 (31.3%) |
| Discusion | ||
| Key results | 18 Summarise key results with reference to study objectives | 16 (100%) |
| Limitations | 19 Discuss limitations of the study, taking into account sources of potential bias or | 9 (56.3%) |
| Interpretation | 20 Give a cautious overall interpretation of results considering objectives, limitations, | 11 (68.8%) |
| Generalisability | 21 Discuss the generalisability (external validity) of the study results | 5 (31.3%) |
| Other information | ||
| Funding | 22 Give the source of funding and the role of the funders for the present study and, | 2 (12.5%) |
| if applicable, for the original study on which the present article is based |
1被动吸烟与肺癌关系的Galbraith图
Galbraith plot for lung cancer among non-smokers associated with passive smoking
2被动吸烟与肺癌关系的L’Abbe图
The L'Abbe plot for lung cancer among non-smokers associated with passive smoking
3中国非吸烟人群被动吸烟与肺癌关系的森林图
Forest plot of odds ratios (OR) and 95% confidence intervals (CI) of lung cancer among non-smokers exposed to passive smoking
4Begg和Egger法检测被动吸烟与肺癌关系的漏斗图
The funnel plot for lung cancer among non-smokers associated with passive smoking through begg's and Egger's test
5各篇文献对meta分析结果的影响
The influence of each document for the outcome of the meta - analysis
不同类别分层非吸烟人群被动吸烟与肺癌的关系
Odds ratios (OR) and 95% confidence intervals (CI) of lung cancer among non-smokers associated with different categories
| Categories | References No. | Combined OR | 95%CI | ||
| Amount of daily | |||||
| passive smoking | |||||
| < 20 cigarettes/day | 3, 5, 12, 13 | 1.49 | 0.88-2.51 | 3.11 | 0.14 |
| ≥20 cigarettes/day | 3, 5, 12, 13 | 1.78 | 1.30-2.43 | 3.61 | 0.000 3 |
| Life period passive | |||||
| smoking exposure | |||||
| Exposure in childhood | 5, 9, 15 | 1.42 | 0.97-2.08 | 3.87 | 0.08 |
| Exposure in adulthood | 5, 9, 15 | 1.50 | 1.23-1.83 | 4.00 | 0.000 1 |
| Gender | |||||
| Male | 4, 9, 10 | 1.36 | 0.93-2.00 | 1.58 | 0.11 |
| Female | 4, 5, 6, 7, 8, 9, 10 | 1.50 | 1.19-1.90 | 6.14 | 0.000 7 |
| Sources of passive smoke | |||||
| exposure | |||||
| Spouse | 6, 7, 8, 15 | 1.18 | 0.80-1.74 | 1.17 | 0.41 |
| Parents | 7, 8, 15 | 1.04 | 0.86-1.27 | 0.43 | 0.67 |
| Workplace | 7, 8, 14, 15, 16 | 1.41 | 1.19-1.66 | 4.00 | < 0.000 1 |